24/7 Customer Support
Valsad, Gujarat, India
WHO-GMP certified fluconazole 50mg tablets optimized for pediatric patients, prophylactic treatment, and mild fungal infections. Complete regulatory documentation and global export support.
| Strength | 50mg |
| Dosage Form | Tablets |
| Route | Oral |
| Indications | Pediatric candidiasis, prophylactic treatment, mild fungal infections, oropharyngeal candidiasis |
| HS Code | 3004.20.90 |
| Regulatory Support | WHO-GMP, ISO 9001, CTD/eCTD dossier, FDA/EMA guidance |
| Shelf Life | 24-36 months |
| Storage | Room temperature (15-30°C), protect from moisture |
| Packaging Options | 10×10 blister packs, 30s, 100s, hospital packs, pediatric formulations |
| Target Markets | Pediatric hospitals, prophylactic programs, general healthcare, developing markets |
Optimized dosing for pediatric patients with mild to moderate fungal infections. Suitable for children with weight-based dosing requirements.
Prevention of fungal infections in immunocompromised patients and those undergoing immunosuppressive therapy.
Treatment of mild fungal infections where lower dosing is appropriate for patient safety and therapeutic efficacy.
Valid WHO-GMP certification for international market access
Detailed COA with complete quality parameters
ICH-compliant stability studies for all climate zones
Complete registration dossier for global submissions
Contact our export team for competitive pricing, regulatory support, and seamless global supply chain solutions.